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Abstract A new peptide, Tc1, containing only 23 amino acids
closely packed by three disulfide bridges was isolated from the
Amazonian scorpion Tityus cambridgei. It blocks reversibly the
Shaker B K+-channels with a Kd of 65 nM and displaces binding
of noxiustoxin to mouse brain synaptosome membranes. It is the
shortest known peptide from scorpion venom that recognizes K+-
channels and constitutes a new structural subfamily of toxin,
classified as alphaKTx 13.1. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Scorpion venoms are rich sources of peptides with a variety
of pharmacological functions, especially those that a¡ect
membrane permeability for Na, K, Ca2 and Cl3 of excit-
able and non-excitable cells (review [1]). They have been ex-
cellent tools to study ion-channel structure and function [2].
About 50 di¡erent peptides from scorpion venoms were re-
cently revised and classi¢ed within 12 subfamilies, based
mainly on structural similarities [3]. All these peptides have
between 30 and 40 amino acid residues and are compacted by
either three or four disul¢de bridges, having in common a
segment of K-helix and two or three anti-parallel L-sheet sec-
ondary foldings, maintained by two disul¢de bridges estab-
lished between a stretch of amino acid sequence CXC and
CXXXC (C, stands for cysteine and X for any amino acid)
that maintain the three-dimensional structure and are essential
for channel recognition [4]. The venom of the Amazonian
scorpion Tityus cambridgei is practically unknown, except
for a short abstract of our group [5]. Here we describe the
¢rst complete amino acid sequence of a toxin from this scor-
pion, that turned out to be a novel structural class of peptide,
containing only 23 amino acids, but e¡ective in displacing the
binding of noxiustoxin (NTX) to mouse brain synaptosomal
membranes and was shown to be an excellent blocker of the
Shaker B K-channel.
2. Materials and methods
2.1. Chemicals, venom and puri¢cation procedure
All chemicals were analytical grade reagents, obtained from sources
already described [6,7]. Scorpions of the species T. cambridgei were
collected in four di¡erent regions of the Amazonas in Brazil (Balbina,
Amazonas state; Ilha Para, Para state; Samuel, Roraima state; San-
tana, Amapa state). Fresh venom was collected from these animals, by
electrical stimulation, at the Butantan Institute (Sa‹o Paulo, Brazil)
and air-dried. The crude venom was dissolved in double distilled
water and spun at 10 000Ug for 15 min. The soluble part of the
venom was separated by high performance liquid chromatography
(HPLC), using a semi-preparative C18 reverse-phase column (Vydac,
Hisperia, CA, USA). Several independent runs with 2 mg each of
soluble venom were separated and the corresponding components
were mixed. Pool of subfractions were further separated in an ana-
lytical C18 reverse-phase column (same company) using a di¡erent
gradient, as indicated in the ¢gure legend.
2.2. Amino acid sequence
The amino acid sequence was performed by automatic Edman deg-
radation in a Beckman LF 3000 protein sequencer (Palo Alto, CA,
USA), using the chemicals and procedure previously described [6].
Samples of approximately 1 nmol each, both of native toxin and
reduced and alkylated peptide were applied to the sequencer.
2.3. Mass spectrometry determination
The molecular masses were obtained on a Voyager DE-PRO (Per-
Septive Biosystems, Framingham, MA, USA) equipped with a nitro-
gen laser (337 nm), as described elsewhere [8].
2.4. Binding assays
NTX, a well known K-channel blocker isolated from the venom of
the scorpion Centruroides noxius (see review [9] was radiolabeled with
125Iodine [10], and used for binding experiments. Mouse brain synap-
tosome membranes were prepared and used for binding assays as also
described [10].
2.5. Electrophysiological measurements
Insect Sf9 cells were grown at 27‡C in Grace’s media (Gibco BRL).
The cells were infected with a recombinant baculovirus containing the
cDNA of Shaker B K-channels [11]. Electrophysiological recordings
were done 48^72 h after the infection, as previously reported [12].
Macroscopic currents were recorded with the whole cell con¢guration
of the patch-clamp technique [13], with an Axopatch 1D (Axon In-
struments, Inc.). The currents were ¢ltered at 5 kHz and sampled
every 100 Ws with a TL1 interface (Axon Instruments, Inc.). The
electrodes were pulled from borosilicate glass (KIMAX 51) to a 1.5
MOhm resistance, and 80% of the series resistance was electronically
compensated. The holding potential used throughout the work was
390 mV. The solutions used were: external bath (in mM): 145 NaCl,
10 Ca2Cl, 10 HEPES^Na at pH 7.2; pipet internal solution (in mM):
90 KF, 30 KCl, 10 EGTA, 10 HEPES^K at pH 7.2.
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3. Results and discussion
Fig. 1 shows the chromatographic pro¢le of T. cambridgei
venom separated in a semi-preparative column. More than 60
di¡erent components are partially distinguishable in this chro-
matogram (Fig. 1a). In order to easily assess possible func-
tions of these components, the binding and displacement ex-
periments using 125I-NTX and mouse brain synaptosome
preparations [10] were used as a starting assay. The ¢rst visi-
ble component, eluting at 21 min in the linear gradient from
5 to 60% acetonitrile for 90 min, corresponded to a peptide
that displaced the binding of 125I-NTX to brain synaptosomal
membranes. The samples corresponding to this elution time
from 10 independent runs were pooled and further applied to
an analytical C18 reverse-phase column, given a major com-
ponent, labeled with an asterisk in the inset of Fig. 1a. This
peptide was used for sequence determination and additional
functional analysis. The pure component corresponds to
about 0.5% of the soluble venom. The automatic amino
acid sequence of the native peptide gave an unique sequence
up to residue 22, with blank spaces, possibly corresponding to
cysteinyl residues. A sample of the peptide was reduced and
alkylated in situ with N-buthylphosphine and acrylamide, fol-
lowing the Beckman manufacturer instructions, and se-
quenced. The alkylated peptide gave unequivocal results for
the ¢rst 22 amino acid residues, as indicated in Fig. 1B. The
last residue Tyr23 was surmised based on molecular mass
determination. The experimental value obtained for the native
peptide was 2446.4, very closely to the theoretical monoiso-
topic mass of 2446.2 for the sequence shown in Fig. 1B. The
sum of the masses of the ¢rst 22 amino acids was 2283.06,
thus the missing amino acid should have a mass of 163, cor-
responding exactly to the mass of tyrosine. In the event that a
dipeptide could be missing, instead of tyrosine, the closest
approximation would be glycine plus cysteine, with a mass
of 160, much farther apart from the experimental value found.
Furthermore, the molecular mass of the native peptide
(2446.4), as obtained from MALDI-TOF, was found to be
2791 after reduction and alkylation of the sample with iodo-
acetamide (mass +57 per residue), showing that the sample
contains six half-cystines, already found by direct Edman deg-
radation analysis. Thus, the peptide Tc1 (from T. cambridgei,
toxin 1), is a 23 amino acid residue peptide, that contains
three disul¢de bridges. Comparative analysis of the amino
acid sequence of this peptide, with those from the literature,
shows that it has a very low similarity to all the other known
[3], and requires the designation of a new subfamily of K-
channel blocking scorpion peptides. The introduction of many
gaps in Fig. 1C is needed in order to approach Tc1 to a
consensus sequence, when compared to the other 12 pre-ex-
isting subfamilies of peptides. Additional structural consider-
ations that support our new classi¢cation (Fig. 1C) will be
discussed at the end of this section.
The venom of T. cambridgei obtained in four di¡erent re-
gions of the Amazonian rain forest of Brazil gave a similar
eluting component and were also used for sequence and mass
spectrometry determination. They all showed the same N-ter-
minal sequence and same molecular mass (data not shown),
suggesting that the presence of exactly the same peptide in the
venom is constant, regardless of the distance (1000 km apart
from each other) in which the T. cambridgei were collected.
The physiological e¡ect of Tc1 was further investigated in
the Sf9 cell culture system, expressing the Shaker B K-chan-
nel, as shown in Fig. 2A^E. In Fig. 2A a series of control
macroscopic K-currents through Shaker B K-channels are
shown. The channels were activated by stepping the mem-
brane from 330 to +50 mV in 10 mV increments from the
holding potential of 390 mV. The subsequent addition of 0.4
WM Tc1 to the external solution completely abolished the K-
Fig. 1. Puri¢cation and sequence of Tc1. A: Soluble venom of T.
cambridgei (2 mg each time) were separated in a preparative C18 re-
verse-phase column of a HPLC system [12], using a linear gradient,
run from 5% bu¡er A (0.12% tri£uoroacetic acid (TFA) in water)
to 60% bu¡er B (acetonitrile with 0.1% TFA) for 90 min, at a £ow
rate of 2 ml/min. The arrow indicates elution of the active compo-
nent, rechromatographed in an analytical column (inset) that corre-
sponded to pure Tc1 peptide (labeled with an asterisk). B: Amino
acid sequence of Tc1 determined from a reduced and alkylated sam-
ple (1 nmol) using the Beckman LF 3000 protein sequencer. The di-
rect sequence was obtained for the ¢rst 22 amino acids (underla-
beled with: ^d^s ), and the last residue Tyr23 as determined by
mass spectrometry analysis (underlabeled with ms). C: Redrawn
consensus comparative analysis taking data of Fig. 2 from our pre-
vious publication [3], into which the amino acid sequence of Tc1
was included, to show that it corresponds to a new subfamily, num-
ber 13. Gaps (^) were introduced in order to increase identity.
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currents at all voltages (Fig. 2B). The e¡ect is completely
reversed by perfusing the cell with the control external solu-
tion (Fig. 2C). In Fig. 2D the peak-current versus voltage
relationship of the traces is shown. Tc1 blockage is not ap-
preciably voltage dependent, and it does not change the ki-
netics of the currents (not shown). Fig. 2E shows that Tc1
blockage of Shaker follows a Michaelis^Menten saturation
relationship with a Kd of 65 nM. Finally in Fig. 2F, a
dose^response curve of binding and displacement experiments
using radiolabeled NTX (125I-NTX) shows that Tc1 competes
with NTX for the binding to the synaptosomal membranes.
The IC50 value is in the order of 200 nM, which can be
considered a low competing a⁄nity for the same channels.
Taking together the results of Fig. 2, they show unequivocally
that Tc1 is a bona ¢de K-channel blocker. It recognizes not
only the Shaker B K-channel, but also the voltage dependent
K-channels present in brain, despite its short length.
It should be noted that Tc1 is a very charged molecule,
Fig. 2. Shaker B Kchannel blockage and NTX displacement. A: Shows the control traces of macroscopic K-currents through Shaker B K-
channels. The channels were activated by 30 ms pulses from 330 to +50 mV in 10 mV increments, delivered every 20 s from the holding po-
tential of 390 mV. B: K-currents left after the addition of 0.4 WM Tc1. C: Complete current recovery after perfusing the cell with the control
external solution. D: Peak-current versus voltage relationship of the traces in A^C; closed circles for control, open triangles after washing and
closed squares for toxin e¡ect. E: Fraction blocked = 13(I/I0), where I0 is the control peak current, and I is the peak current in the presence of
the indicated toxin concentration. Each point is the mean þ S.D. (for three independent experiments). The line is the ¢t of the points with a Mi-
chaelis^Menten equation, Kd = 65 nM. The inset is the double reciprocal plot of the points, r = 0.991. F: Shows the binding and displacement
experiments to mouse brain synaptosome membranes as described [10], using 125I-NTX for binding and cold Tc1, at the concentrations indi-
cated, as competitor. The calculated IC50 was in the order of 200 nM.
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composed of 30% positively charged residues, 30% hydropho-
bic amino acids, 26% cysteines and no acidic residues (Asp or
Glu).
Finally, it is worth mentioning some additional features
that warrant the classi¢cation of Tc1 in a new special sub-
family of scorpion K-toxins, here denominated alphaKTx
13.1, because it is the ¢rst member of the subfamily 13. To
begin with, it is the shortest of all known sequences of scor-
pion K-channels blockers, that although having the signa-
ture sequence CXC, CXXXC (C for cysteine and X for any
amino acid) segments tighten with two conserved disul¢de
bridges, it lacks entirely the N-terminal segment and also
lacks a substantial part of the K-helix forming region of other
K-channel toxins. For example, the three-dimensional struc-
ture of NTX (the competing toxin for the assay in Fig. 2F)
shows that residues Lys11 to Leu20 are forming three turns of
K-helix, whereas Thr1^Asn4, Ala25^Cys29 and Lys33^Tyr37
are involved in anti-parallel L-sheet formation [14]. Between
the third and fourth cysteinyl residue of NTX there are 11
amino acids, whereas in Tc1 there are only ¢ve. However, the
last segment of Tc1, residues Lys14^Tyr23 do correspond
considerably to other K-toxins, with overall identities in the
order of 30^40%. If the sequences are manually compared
(data not shown), introducing gaps to maximize identity and
aligning the cysteines in equivalent positions, the percentage
of identity with NTX of subfamily 2 (see [2]), gave 41% iden-
tity, which is one of the highest scores obtained. For Agitoxin
1 of subfamily 3 the identity was 37%; for toxin TsTxIV of
Tityus serrulatus (related species), belonging to subfamily 12,
it was 36%; for Pi1 of subfamily 6 it was 34% and for BmPO1
of subfamily 8 it was 31%. The identity with all other scorpion
toxins is lower than 50%. The essential residue Lys27 in cha-
rybdotoxin [2] that corresponds to Lys28 in NTX [2,9] would
correspond to Lys14 in Tc1. Nevertheless, Tc1 with half the
size of the other peptides has a similar function. It has been
shown by side-directed mutagenesis [2,15] that the recognition
site of most scorpion toxins blockers speci¢c for K-channels
reside in the C-terminal segment of the molecules, despite the
fact that for some toxins, such as NTX [10], Pi2 and Pi3 from
Pandinus imperator [16], some residues of the N-terminal re-
gion also play a critical role in the recognition and binding to
K-channels. Here, the structural analysis of Tc1 supports the
idea that the C-terminal segment of the peptide is the one
showing the highest sequence identity to other K-channel
blockers and that the N-terminal segment is probably less
important. Thus, Tc1 is an excellent candidate for three-di-
mensional structure determination and site-directed mutagen-
esis in order to con¢rm its recognition site towards K-chan-
nels.
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